A review of atomoxetine effects in young people with developmental disabilities
详细信息 查看全文
- 作者：Michael G. Amana ; aman.1@osu.edu" class="auth_mail ; Tristram Smithb ; L. Eugene Arnolda ; Patricia Corbett-Dickb ; Rameshwari Tumuluruc ; Jill A. Hollwaya ; Susan L. Hymanb ; Marissa Mendoza-Burchamc ; Xueliang Pand ; Daniel W. Mruzekb ; Luc Lecavaliera ; Lynne Levatob ; Laura B. Silvermanb ; Benjamin Handenc
- 关键词：Atomoxetine (Strattera) ; Review ; Developmental disabilities ; Autism spectrum disorders
- 刊名：Research in Developmental Disabilities
- 出版年：June 2014
- 年：2014
- 卷：35
- 期：6
- 页码：1412-1424
- 全文大小：424 K
文摘
- •
Ten published trials and one case study of atomoxetine in developmental disabilities.
- •
Only two controlled clinical trials; and only one non-acute extension.
- •
Individuals with intellectual disability especially neglected in studies.
- •
Improved attention, impulsivity, overactivity, oppositional behavior often reported.
- •
Common adverse events include anorexia, nausea, and irritability/mood.